Tracing the mutated HTT and haplotype of the African ancestor who spread Huntington disease into the Middle East
Purpose We aimed to determine the origin and genetic characteristics of Huntington disease (HD) in the Middle East. Methods We performed genetic and genealogical analyses to establish the ancestral origin of the HTT pathgenic variant from a large kindred from Oman (hereafter called the OM-HD-01 pedi...
Saved in:
Published in | Genetics in medicine Vol. 22; no. 11; pp. 1903 - 1908 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.11.2020
Elsevier Limited |
Subjects | |
Online Access | Get full text |
ISSN | 1098-3600 1530-0366 1530-0366 |
DOI | 10.1038/s41436-020-0895-1 |
Cover
Loading…
Summary: | Purpose
We aimed to determine the origin and genetic characteristics of Huntington disease (HD) in the Middle East.
Methods
We performed genetic and genealogical analyses to establish the ancestral origin of the
HTT
pathgenic variant from a large kindred from Oman (hereafter called the OM-HD-01 pedigree) by single-nucleotide polymorphism and dense haplotype analysis genotyping.
Results
We traced the oldest ancestry of the largest, eight-generation, OM-HD-01 pedigree (
n
= 302 subjects, with 54 showing manifest HD) back to sub-Saharan Africa and identified a unique HD haplotype carried by all pedigree members, which consisted of portions of the C6 and C9 haplotypes and was carried by all affected members. Such a unique HD haplotype was of African origin and appeared to be associated with large CAG repeat expansions on average and high frequency of juvenile-onset HD. Three other families from the same area were also identified and found carrying a Caucasian HD haplotype A, also shared by most families of Arab ancestry.
Conclusion
Mutated
HTT
spread into Middle East with a unique haplotype of African origin, appeared to be associated with juvenile-onset, a HD condition frequently occurring in Black Africans, and may have a significant impact on further development of novel targeted genetic therapies. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1098-3600 1530-0366 1530-0366 |
DOI: | 10.1038/s41436-020-0895-1 |